Health in South-East Asia (WHO region) 202 indicators covering health for South-East Asia (WHO region). IndicatorLatest Year10-yr change Rank Incidence of tuberculosis 201 2024 down 18.3% 3rd Number of incident tuberculosis cases 64,000 2024 down 64.2% 6th Number of deaths due to tuberculosis, excluding HIV 433,000 2024 down 19.8% 3rd Deaths due to tuberculosis among HIV-negative people 24 2024 down 25.0% 3rd Overweight prevalence among children under 5 years of age (%) 3.4% 2024 up 47.8% 13th Stunting numbers among children under 5 years of age (millions) 44,289 2024 down 25.2% 6th Tuberculosis - new and relapse cases 3.13 million 2024 up 45.2% 3rd Tuberculosis treatment coverage 85 2024 up 60.4% 1st Mean BMI (kg/m²) 22.2 2016 up 3.7% 12th Rubella - number of reported cases 2,940 2025 down 32.6% 7th Treatment success rate: new TB cases 90 2023 up 2.3% 3rd Yellow fever - number of reported cases 0 2025 — 8th Poliomyelitis - number of reported cases 1 2018 down 99.8% 5th Mortality rate among children ages 10 to 14 years 2.63 2020 down 29.9% 4th UHC Service Coverage sub-index on infectious diseases 80 2023 up 48.1% 8th UHC Service Coverage sub-index on service capacity and access 73 2023 up 15.9% 8th UHC Service Coverage sub-index on reproductive, maternal, newborn and 70 2023 down 1.4% 9th UHC Service Coverage Index 68 2023 up 19.3% 8th UHC Service Coverage sub-index on noncommunicable diseases 53 2023 up 20.5% 12th Stillbirth rate 12.07 2023 down 33.3% 6th Rotavirus vaccines completed dose (RotaC) immunization coverage among 77.0% 2025 — 1st Current health expenditure (CHE) as percentage of gross domestic 5.3% 2023 up 16.2% 11th External health expenditure (EXT) as percentage of current health 5.4% 2023 down 41.4% 7th Domestic general government health expenditure (GGHE-D) as percentage 47.8% 2023 up 15.6% 7th Out-of-pocket expenditure as percentage of current health expenditure 41.0% 2023 down 6.7% 2nd Domestic general government health expenditure (GGHE-D) as percentage 2.9% 2023 up 47.3% 7th Domestic general government health expenditure (GGHE-D) as percentage 8.2% 2023 up 15.2% 8th Domestic private health expenditure (PVT-D) as percentage of current 46.8% 2023 down 5.4% 2nd Current health expenditure (CHE) per capita in US$ 244.94 2023 up 62.4% 8th Domestic private health expenditure (PVT-D) per capita in US$ 69.45 2023 up 9.1% 8th Domestic general government health expenditure (GGHE-D) per capita in 167.49 2023 up 110.4% 8th Mumps - number of reported cases 3,253 2025 down 92.4% 11th Incidence of tuberculosis (per 100 000 population) 4.7 2023 down 57.3% 6th Estimated antiretroviral therapy coverage among people living with HIV 22.0% 2025 up 69.2% 12th External health expenditure (EXT) per capita in US$ 8 2023 up 5.8% 8th Congenital Rubella Syndrome - number of reported cases 77 2025 down 44.6% 8th Raised blood pressure (SBP>=140 OR DBP>=90) 26.33 2019 down 7.8% 7th Raised blood pressure (SBP>=140 OR DBP>=90) 25.7 2019 down 4.9% 9th Hypertension effective treatment coverage (controlled hypertension) 13.6% 2019 up 70.0% 9th Hypertension: effective treatment coverage (controlled hypertension) 13.3% 2019 up 70.5% 13th Hypertension treatment coverage among adults aged 30-79 with 31.0% 2019 up 33.9% 13th Hypertension treatment coverage among adults aged 30-79 with 31.8% 2019 up 31.7% 9th Hypertension: diagnosis coverage among adults aged 30-79 with 39.8% 2019 up 28.4% 16th Hypertension: diagnosis coverage among adults aged 30-79 with 39.0% 2019 up 30.1% 15th Hypertension among adults aged 30-79 years, prevalence, crude 30.3 2019 up 2.5% 16th Pneumococcal conjugate second or third-dose vaccines (PCVc) 92.0% 2025 up 1,740.0% 1st Treatment success rate: previously treated TB cases 90 2023 up 34.3% 1st Adolescent birth rate 0.287 2025 down 65.5% 5th Reported number of people receiving antiretroviral therapy 780,000 2025 up 66.0% 7th Estimated number of people (all ages) living with HIV 3.60 million 2025 unchanged 4th Prevalence of HIV among adults aged 15 to 49 0.2% 2025 down 33.3% 5th Prevalence of insufficient physical activity among adults aged 18+ 43.2% 2022 up 36.2% 1st Prevalence of insufficient physical activity among adults aged 18+ 43.7% 2022 up 33.1% 1st TB patients with known HIV status 89.0% 2024 up 64.8% 2nd Number of people dying from HIV-related causes 40,000 2025 down 71.4% 6th Number of new HIV infections 82,000 2025 down 36.9% 6th Confirmed cases of RR-/MDR-TB 61,774 2024 up 96.6% 3rd Tested TB patients HIV-positive 1.7% 2024 down 66.0% 10th New cases tested for RR-/MDR-TB 91.0% 2024 up 1,968.2% 1st Age-standardized suicide rates 10.08 2021 down 20.5% 4th ← Previous Page 2 of 4 Next →